FAAH and glaucoma: FAAH, known for hydrolyzing fatty acid amides, has been implicated for regulating endocannabinoid signaling within the eye and modulating intraocular pressure, making it a target for glaucoma therapies (Spadoni et al, 2018; Miller et al, 2020).